MENU
SPRO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Spero Therapeutics (SPRO) Ownership - Who owns Spero Therapeutics?
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
46
Web
https://www.sperotherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
105.23M
P/E Ratio
10.75
Total Cash
31.19M
Projected Growth
N/A
Total Debt
3.62M
Revenue
34.09M
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash/Share
0.55
Total Debt/Equity
N/A
Revenue/Share
0.62 USD as % of share price
Fundamentals
SPRO
Capitalization
105M
P/E Ratio
10.75
Risk (Beta)
0.59
Dividend Yield
N/A
Total Cash
31.2M
Total Cash/Share
0.55
Total Debt
3.62M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.62%
Revenue
34.1M
ROE
N/A
Book Value
32.8M
P/B Ratio
3.21
Cash Flow
N/A
Earnings
-0.98
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
56K
Current Ratio
3.97
Current Revenue Per Employee
368812.50
Dividends Per Share - Security
N/A
EBITDA
-56.36M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-50.57
Shares Held By Institutions
22.3M
Shares Outstanding - Current
56.3M
Total Liabilities
29.3M
Total Volume MTD
N/A
Value
N/A
Gain YTD
81.553
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SPRO showed earnings on August 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a developer of novel therapies for the treatment of resistant bacterial infections
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
46
Web
https://www.sperotherapeutics.com